Bixiye
QP60-25 MHCP Pharmacy Benefit Exclusion for Emrelis™, Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3181 - 3190 ee natiijooyinka 3607
Bixiye
QP59-25 Commercial Pharmacy Benefit Exclusion for Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP58-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP57-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2025
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP56-25 MHCP Enhanced Authorization Submissions through Availity Essentials
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP55-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Faa'iidooyinka & Caymiska
Warqada dawada ee dhakhtar qoray & farmashiye
2026 Medicare Advantage Core and Comfort Formulary
List of covered drugs.